Trial intelligence / Profile preview

Prenatal Spermine for Premature Fetal Gut Maturation in Rabbits

NCT04004091Phase 1Completed

Start
Mar 2019
Primary completion
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of Spermine in necrotizing enterocolitis (NEC) (6 arms). Primary endpoints: Occludin Expression at 2 weeks, Beta-catenin Expression at 2 weeks and 1 more. Started Mar 2019; status: completed.

02

Drugs

Spermine
03

Conditions

necrotizing enterocolitis (NEC)

Beyond the preview

Go deeper on NCT04004091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04004091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call